Abstract
Filariasis is a significant cause of morbidity and a public health concern in most tropical countries. These diseases are usually contracted in childhood and most often diagnosed in adulthood. This study aimed to identify biochemical markers associated with filariasis and the endobacteria present in microfilariae.
This was a cross-sectional analytical study within a hospital setting. Persons aged from six years and above were included in the study. They were then clustered into asymptomatic and symptomatic. Data was collected from February to June 2023. Blood, urine, and skin samples were collected and analysed by microscopy to identify microfilariae. The plasmatic and urinary markers were evaluated by spectrophotometry and protein fraction was monitored by electrophoresis. The data was analysed using SPSS 25 with the significant threshold set at 0.005.
A total of 55 persons were included in the study, representing 74,32% of the total population questioned. The sex ratio (F/M) was 2.66. The infection rate was 18.2% Onchocerca volvulus, 54.54% Mansonella perstans, 22.72% Loa loa and 4.54% Wuchereria bancrofti. Protein levels were 35% higher in the asymptomatic with no parasite, 80% in the asymptomatic with detected parasite and 91.67% in the symptomatic. The decrease in albumin fraction and increase in gamma fractions seem to be correlated with the presence of parasites in the blood.
These results suggest that protidemia and serum protein are significant indicators in the diagnosis of filariasis.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
In order to comply with the rules of biomedical ethics, we requested and obtained: - Ethical clearance from the institutional Ethical committee of the University of Douala (3586/CEI-Udo/06/2023/M.) Research authorization from: - Regional Hospital of Nkongsamba (072/AR/MINSANTE/DRSPL/HRN/23) - Njombe-Pendja health district (148/23MINSANTE/DRSPL/DSNP) Ekol-mbeng health centre (001/L/MS/DRSL/SSDN/CSIE)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
the data are available at the FMSP-Udo
